These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 28592228)

  • 1. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
    Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
    BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
    Nuwormegbe SA; Sohn JH; Kim SW
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A.
    Choi YJ; Koo JB; Kim HY; Seo JW; Lee EJ; Kim WR; Cho JY; Hahm KB; Hong SP; Kim DH; Yoo JH
    Stem Cell Res Ther; 2019 Sep; 10(1):291. PubMed ID: 31547873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
    Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
    Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism.
    Zhou B; Buckley ST; Patel V; Liu Y; Luo J; Krishnaveni MS; Ivan M; DeMaio L; Kim KJ; Ehrhardt C; Crandall ED; Borok Z
    PLoS One; 2012; 7(6):e38827. PubMed ID: 22745681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
    Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
    Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation.
    Jeon KI; Kulkarni A; Woeller CF; Phipps RP; Sime PJ; Hindman HB; Huxlin KR
    Am J Pathol; 2014 May; 184(5):1429-45. PubMed ID: 24650561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone inhibits transforming growth factor-β1 mediated fibrogenesis in ADPKD cyst-lining epithelial cells.
    Liu Y; Dai B; Xu C; Fu L; Hua Z; Mei C
    PLoS One; 2011; 6(12):e28915. PubMed ID: 22174924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
    Jeon KI; Phipps RP; Sime PJ; Huxlin KR
    Exp Eye Res; 2015 Sep; 138():52-8. PubMed ID: 26142957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts.
    Wang W; Liu F; Chen N
    Mediators Inflamm; 2007; 2007():62641. PubMed ID: 18274641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta.
    Kawai T; Masaki T; Doi S; Arakawa T; Yokoyama Y; Doi T; Kohno N; Yorioka N
    Lab Invest; 2009 Jan; 89(1):47-58. PubMed ID: 19002105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrotic Actions of Peroxisome Proliferator-Activated Receptor γ Ligands in Corneal Fibroblasts Are Mediated by β-Catenin-Regulated Pathways.
    Jeon KI; Phipps RP; Sime PJ; Huxlin KR
    Am J Pathol; 2017 Aug; 187(8):1660-1669. PubMed ID: 28606794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.
    Li Y; Wen X; Spataro BC; Hu K; Dai C; Liu Y
    J Am Soc Nephrol; 2006 Jan; 17(1):54-65. PubMed ID: 16291834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
    Lee YJ; Han HJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
    Wang WM; Liu F; Chen N
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):740-4. PubMed ID: 16681946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.
    Hao GH; Niu XL; Gao DF; Wei J; Wang NP
    Br J Pharmacol; 2008 Apr; 153(7):1409-19. PubMed ID: 18278065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal myofibroblast TRPC6 channel may contribute to stenotic fibrosis in Crohn's disease.
    Kurahara LH; Sumiyoshi M; Aoyagi K; Hiraishi K; Nakajima K; Nakagawa M; Hu Y; Inoue R
    Inflamm Bowel Dis; 2015 Mar; 21(3):496-506. PubMed ID: 25647156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitive effect of troglitazone on TGF-beta(1) and fibronectin expression in human peritoneal mesothelial cells].
    Liu H; Peng YM; Liu FY; Liu YH; Li LY; Li J; Chen X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):473-9. PubMed ID: 17611328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone attenuates activation of human Tenon's fibroblasts induced by transforming growth factor-β1.
    Fan F; Li Y; Duan X; Zhao T; Pan D; Chen H
    Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1213-20. PubMed ID: 22215258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.